MedPath

KOVACH EYE INSTITUTE

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Assessing the Efficacy and Safety fo DEXTENZA, Sustained Release Dexamethasone 0.4 mg Insert(s) for the Treatment of Pain, Inflammation, and Cystoid Macular Edema Following 27 Gauge Vitrectomy With Internal Limiting Membrane Peel for the Treatment of Retinal Edema Associated With Macular Pucker.

Phase 4
Recruiting
Conditions
Vitrectomy
Macular Pucker
Retinal Edema
Interventions
First Posted Date
2020-08-06
Last Posted Date
2023-06-29
Lead Sponsor
Kovach Eye Institute
Target Recruit Count
60
Registration Number
NCT04501367
Locations
🇺🇸

Kovach Eye Institute, Elmhurst, Illinois, United States

Prospective Evaluation of the Tecnis Symfony Intraocular Lens (IOL)

Not Applicable
Conditions
Cataract Senile
Cataract
Interventions
Device: Symfony implantation
First Posted Date
2018-07-06
Last Posted Date
2018-07-06
Lead Sponsor
Kovach Eye Institute
Target Recruit Count
200
Registration Number
NCT03579368
© Copyright 2025. All Rights Reserved by MedPath